Choose Your News
Loading...
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Thumbnail
The Charlottesville-based Blue Ridge Poison Center and the Food and Drug Administration are putting out a warning for the deadly risks associated with the plant Kratom. [Read More]
Thumbnail
BC-APFN-US-MED--FDA-Breast Cancer Drug, 1st Ld-Writethru,397 US OKs 1st drug aimed at women with inherited breast cancer AP Photo NYBZ566 Eds: Updates with details, comments, context. With AP Photo NYBZ566. With AP Photos. By LINDA A. JOHNSON AP Medical Writer U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy. The drug has been on the market since 2014 for ovarian cancer, and is the first in a new... [Read More]
The U.S. Food and Drug Administration on Friday approved the first treatment for advanced breast cancer caused by inherited mutations in BRCA genes.The agency initially approved Lynparza (olaparib tablets) in 2014 to treat advanced ovarian cancer caused by mutations in BRCA1 or BRCA2.The expanded approval follows the model of "developing drugs that target the underlying genetic causes of cancer, often across cancer types," Richard Pazdur, director of the FDA's oncology center of excellence, said in... [Read More]
The U.S. Food and Drug Administration on Friday approved the first treatment for advanced breast cancer caused by inherited mutations in BRCA genes.The agency initially approved Lynparza (olaparib tablets) in 2014 to treat advanced ovarian cancer caused by mutations in BRCA1 or BRCA2.The expanded approval follows the model of "developing drugs that target the underlying genetic causes of cancer, often across cancer types," Richard Pazdur, director of the FDA's oncology center of excellence, said in... [Read More]
U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited, flawed gene. The Food and Drug Administration yesterday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy. The drug has been on the market since 2014 for ovarian cancer, and is the first in a new class of medicines called PARP inhibitors to be approved for breast cancer. PARP inhibitors prevent cancer cells from fixing problems in their DNA. [Read More]
Thumbnail
According to a press release by the Food and Drug Administration, the drug Lynparza was approved for patients whose breast cancer has metastasized and who carry a mutation in the BRCA1 and BRCA2 genes. [Read More]
Subcommittee on Oversight and InvestigationsMeeting Date: Friday, January 19, 2018 9:00 AM 2123 RHOB (Status: Scheduled) [Read More]
Thumbnail
The U.S. Food and Drug Administration is changing safety label requirements for prescription cough and cold medications that contain opioids, further limiting their use in children.The federal agency last April began requiring prescription cough and cold medications that contain codeine to carry its strongest warning, called a contraindication, stating that they should not be used in children younger than 12.On Thursday, the FDA announced it is expanding the requirements to children younger... [Read More]
Thumbnail
The Food and Drug Administration approved AstraZeneca's Lynparza for patients with inherited BRCA gene mutations... [Read More]
Thumbnail
The student news site of Southern Illinois University... [Read More]
Thumbnail
The U.S. Food and Drug Administration will now require safety labeling changes to limit the use of prescription opioid cough and cold medicines. [Read More]
Thumbnail
The U.S. Food and Drug Administration will now require safety labeling changes to limit the use of prescription opioid cough and cold medicines. [Read More]
The Subcommittee on Oversight and Investigations, chaired by Rep. Gregg Harper (R-MS), today announced a hearing for Friday, January 19, 2018, at 9 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled, "Safety of the U.S. Food Supply: Continuing Concerns Over the Food and Drug Administration's Food-Recall …... [Read More]
Thumbnail
The U.S. Food and Drug Administration issued a warning of possible contamination of ice cream bars sold under numerous brands at various stores across the country. [Read More]
Thumbnail
Do you reach for the cough syrup when your little one catches a cold? Make sure it doesn't include codeine or hydrocodone, because the Food and Drug Administration says the opioid ingredients... [Read More]
Thumbnail
Marie McCullough, Philadelphia Inquirer and Daily News... [Read More]
Thumbnail
Lynparza, or olaparib, has been approved by the U.S. Food and Drug Administration to treat spreading breast cancer caused by a BRCA gene mutation. [Read More]
Thumbnail
A Maryland company can now begin marketing its device, which could change the way breast cancer is treated, after it received government clearance last month. The Food and Drug Administration grant…... [Read More]
Thumbnail
Hom/Ade Foods, Inc is voluntarily recalling Mary B's® brand biscuits due to potential Listeria contamination, according to a news release from the U.S. Food and Drug Administration. [Read More]
Thumbnail
U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have already undergone chemotherapy. The drug has been on the market since 2014 for ovarian cancer, and... [Read More]
Loading...
Preview